Haffkine Biopharmaceuticals

Haffkine Biopharmaceuticals

Mumbai, India· Est.

A government-owned Indian biopharmaceutical company producing essential vaccines, antitoxins, and pharmaceutical products for public health.

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

AI Company Overview

A government-owned Indian biopharmaceutical company producing essential vaccines, antitoxins, and pharmaceutical products for public health.

Infectious DiseaseToxicology

Technology Platform

Traditional biologics manufacturing platform for bacterial/viral vaccines and polyclonal antisera production using equine hyperimmunization and plasma fractionation.

Opportunities

Opportunities include leveraging its government mandate to modernize facilities and expand production of essential vaccines and antitoxins for India's growing public health needs, including potential for new vaccine introductions.

Risk Factors

Key risks include dependence on government procurement policies and budgets, potential technological lag compared to private sector innovators, and operational inefficiencies inherent in some state-owned enterprises.

Competitive Landscape

HBPCL competes with large Indian vaccine manufacturers like Serum Institute of India and Bharat Biotech, as well as multinationals, but is differentiated by its government ownership, focus on affordable public health products, and unique expertise in traditional antitoxin production.